PharmaBoardroom

Interview: Dr. Marco A. Martinez Rios – General Director,…

Dr. Marco A. Martinez Rios, General Director of the National Institute of Cardiology in Mexico elaborates on the institution's rich history in Mexico…

Gilles Pluntz – Chairman of the Group Operating Committee…

The Chairman of Ferring’s Group Operating Committee and Senior Vice President Europe-Canada elaborates on how Europe can be the thinking engine for…

Interview: Leslie Chua – General Manager Asia Pacific,…

In an exclusive interview with Leslie Chua, the General Manager of the Solutions Division at Hitachi Medical Systems, he elaborates on how the…

Interview: Giovan Maria Zanini – Board member, Swissmedic…

An expert in the implementation of Swiss federal laws within Switzerland’s constituent cantons, Giovan Maria Zanini discusses the evolution of Swiss…

Interview: Alan Smithers – CEO, IFA Celtics, Mexico

Alan Smithers, CEO at IFA Celtics, highlights the obesity as a national healthcare challenge and explains the company’s strategy to enlarge its…

Interview: Dr. Ignazio Cassis – President, curafutura…

Switzerland may have a world class healthcare system, but small adjustments are needed to ensure incentives for payer and providers are properly…

Interview: Thomas Früh – CEO, Bachem, Switzerland

Advances in delivery technology and manufacturing costs have driven a surge of activity in peptide drug development, says Thomas Früh, CEO of Bachem…

Interview: Daniel Pedrett – CEO, Rohner Chem, Switzerland

Outsourcing of API synthesis has stabilized in the decade since Rohner Chem entered the pharma sector in earnest, and according to CEO Daniel Pedrett…